Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) continues to raise worldwide concerns due to its pandemic potential. Increased MERS cases and no licensed MERS vaccines highlight the need to develop safe and effective vaccines against MERS. We have previously demonstrated that a receptor-binding domain (RBD)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hum Vaccin Immunother
Hauptverfasser: Wang, Yufei, Tai, Wanbo, Yang, Jie, Zhao, Guangyu, Sun, Shihui, Tseng, Chien-Te K., Jiang, Shibo, Zhou, Yusen, Du, Lanying, Gao, Jimin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2017
Schlagworte:
Research Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512770/
https://ncbi.nlm.nih.gov/pubmed/28277821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1296994
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge